Recital 7, Regulation (EU) 2017/2065

In forcesince 13 Nov 2017cited 1×

The Authority identified in its conclusion that some toxic effects were observed on endocrine organs. Therefore 8-hydroxyquinoline should also be regarded as having endocrine-disrupting properties. The Authority communicated its conclusion to the applicant, the Member States and the Commission and made it available to the public.

  • Judgment of the General Court (Fifth Chamber) of 19 December 2019. Probelte, SA v European Commission.Decision

    Third, on the date on which the applicant sent to the Commission the studies referred to in paragraph 13 above, namely on 31 May 2017, no option to submit additional information or observations was available under Articles 12 and 13 of …

    19 Dec 2019 · 62018TJ0067